Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffery J. Wheeler
Inhibition of Integrin-Linked Kinase by a Selective Small Molecule Inhibitor, QLT0254, Inhibits the PI3K/PKB/mTOR, Stat3, and FKHR Pathways and Tumor Growth, and Enhances Gemcitabine-Induced Apoptosis in Human Orthotopic Primary Pancreatic Cancer Xenografts
Cancer Research
Cancer Research
Oncology
Related publications
Small Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
Cancer Research
Cancer Research
Oncology
A Small Molecule FAK Kinase Inhibitor, GSK2256098, Inhibits Growth and Survival of Pancreatic Ductal Adenocarcinoma Cells
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Demethylzeylasteral (ZST93) Inhibits Cell Growth and Enhances Cell Chemosensitivity to Gemcitabine in Human Pancreatic Cancer Cells via Apoptotic and Autophagic Pathways
International Journal of Cancer
Cancer Research
Oncology
Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
PLoS ONE
Multidisciplinary
Small-Molecule Inhibitor of BCL-2 (TW-37) Suppresses Growth and Enhances Cisplatin-Induced Apoptosis in Ovarian Cancer Cells
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Dual Inhibition of ULK1 and mTOR Enhances Tumor Cell Apoptosis
Cancer Discovery
Oncology
Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer
Journal of Cancer Therapy
Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity
Acta Pharmacologica Sinica
Medicine
Pharmacology
Correction: A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth in Vitro and in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
